The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors
Abstract
We have defined a human breast tumor associated antigen using a murine monoclonal antibody (MAb DF3) prepared against a membrane-enriched fraction of a human breast carcinoma. This antigen has a MW of 290 kD and is detectable on the cell surface of human breast carcinoma cells using a live cell radioimmunoassay and fluorescence flow cytometry. More important, immunoperoxidase staining with MAb DF3 clearly distinguishes malignant and benign breast lesions. A cytoplasmic staining pattern has been observed with 40 of 51 (78%) breast carcinomas, but only one of 13 fibroadenoma or fibrocystic disease specimens. In contrast, reactivity of benign breast lesions with MAb DF3 primarily occurs along apical borders on ductules. These results demonstrate that the DF3 antigen is present on apical borders of more differentiated secretory mammary epithelial cells and in the cytosol of less differentiated cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Taylor‐Papadimitriou, J., Peterson, J. A., Arklie, J., Burchell, J., Ceriani, R. L., & Bodmer, W. F. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910280104 · Cited by 601
A spectrum of monoclonal antibodies reactive with human mammary tumor cells.
Colcher, D. M., Hand, P. H., Nuti, M., & Schlom, J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3199 · Cited by 562
Self-citationSloane, J. P., & Ormerod, M. G. (1981) · Cancer · doi:10.1002/1097-0142(19810401)47:7<1786::aid-cncr2820470711>3.0.co;2-8 · Cited by 402
Arklie, J., Taylor‐Papadimitriou, J., Bodmer, W., Egan, M., & Millis, R. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910280105 · Cited by 329
Nuti, M., Teramoto, Y. A., Mariani‐Costantini, R., Hand, P. H., Colcher, D. M., & Schlom, J. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290509 · Cited by 326
Self-citationGeneration of monoclonal antibodies reacting with normal and cancer cells of human breast.
Ménard, S., Tagliabue, E., Canevari, S., Fossati, G., & COLNAGHI, M. I. (1983) · PubMed · Cited by 231
Lundy, J., Thor, A. D., Maenza, R. M., Schlom, J., Forouhar, F., Testa, M. A., & Kufe, D. W. (1985) · Breast Cancer Research and Treatment · doi:10.1007/bf01806021 · Cited by 67
Self-citation
Cited by
Mucins in cancer: function, prognosis and therapy
Kufe, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2761 · Cited by 1,396
Self-citationAberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens
(1989) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60215-8 · Cited by 1,087
Terminal Differentiation of Human Breast Cancer through PPARγ
Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., & Spiegelman, B. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80047-7 · Cited by 851
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Kulasingam, V., & Diamandis, E. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1187 · Cited by 771
Kufe, D. W. (2013) · Oncogene · doi:10.1038/onc.2012.158 · Cited by 437
Self-citationA Review and Proposed Nomenclature for Major Proteins of the Milk-Fat Globule Membrane,
Mather, I. H. (2000) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(00)74870-3 · Cited by 420
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
Thomas, D., Rathinavel, A. K., & Radhakrishnan, P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188464 · Cited by 372
CA 15-3: Uses and limitation as a biomarker for breast cancer
Duffy, M. J., Evoy, D., & McDermott, E. W. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.039 · Cited by 371
Ligtenberg, M. J., Vos, H. L., Gennissen, A. M., & Hilkens, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39399-8 · Cited by 369
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
Ren, J., Agata, N., Chen, D., Li, Y., Yu, W.-H., Huang, L., Raina, D., Chen, W., Kharbanda, S., & Kufe, D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00020-0 · Cited by 325
Self-citationComparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
Hayes, D. F., Zurawski, V. R., & Kufe, D. W. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.10.1542 · Cited by 319
Self-citationStubbs, J. D., Lekutis, C., Singer, K. L., Bui, A., Yuzuki, D., Srinivasan, U., & Parry, G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8417 · Cited by 313
Interaction of the DF3/MUC1 Breast Carcinoma-associated Antigen and β-Catenin in Cell Adhesion
Yamamoto, M., Bharti, A., Li, Y., & Kufe, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12492 · Cited by 308
Self-citationIsolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.
Siddiqui, J., Abe, M., Hayes, D., Shani, E., Yunis, E., & Kufe, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2320 · Cited by 308
Self-citationMucin-type O-glycosylation and its potential use in drug and vaccine development
Tarp, M. A., & Clausen, H. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.09.010 · Cited by 303
Gendler, S. J., Burchell, J. M., Duhig, T., Lamport, D., White, R., Parker, M., & Taylor-Papadimitriou, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6060 · Cited by 289
Tarp, M. A., Sørensen, A. L., Mandel, U., Paulsen, H., Burchell, J., Taylor-Papadimitriou, J., & Clausen, H. (2007) · Glycobiology · doi:10.1093/glycob/cwl061 · Cited by 262
MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines
Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Magarian‐Blander, J., & Barratt‐Boyes, S. M. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00077.x · Cited by 261
Simple Sugars to Complex Disease—Mucin-Type O-Glycans in Cancer
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2014.11.002 · Cited by 260
Li, Q., Kuwahara, H., Yin, L., Li, Y., Ren, J., Yu, W.-H., Carraway, K. L., & Kufe, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100359200 · Cited by 257
Self-citationBand, V, & Sager, R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1249 · Cited by 194
Dhanisha, S. S., Guruvayoorappan, C., Drishya, S., & Abeesh, P. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.12.006 · Cited by 194
MUC1 (CD227): a multi-tasked molecule
Apostolopoulos, V., Stojanovska, L., & Gargosky, S. E. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2014-z · Cited by 138
Metadata
- Authors
- KUFE, D., INGHIRAMI, G., ABE, M., HAYES, D., JUSTI-WHEELER, H., & SCHLOM, J.
- Venue
- Hybridoma
- Publisher
- SAGE Publications
- Published
- 1984-01
- Volume
- 3
- Issue
- 3
- Pages
- 223-232
- ISSN
- 0272-457X (ISSN-L)
- OpenAlex
- W2023761151
- Cited by
- 573
- References
- 8
- FWCI
- 18.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.